These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Myasthenia gravis syndrome associated with trimethadione. Booker HE; Chun RW; Sanguino M JAMA; 1970 Jun; 212(13):2262-3. PubMed ID: 4987393 [No Abstract] [Full Text] [Related]
4. Association of trimethadione therapy and myasthenia gravis. Peterson H N Engl J Med; 1966 Mar; 274(9):506-7. PubMed ID: 4955435 [No Abstract] [Full Text] [Related]
5. Trimethadione and human teratogenesis. German J; Kowal A; Ehlers KH Teratology; 1970 Nov; 3(4):349-62. PubMed ID: 5006237 [No Abstract] [Full Text] [Related]
6. The fetal trimethadione syndrome: report of an additional family and further delineation of this syndrome. Feldman GL; Weaver DD; Lovrien EW Am J Dis Child; 1977 Dec; 131(12):1389-92. PubMed ID: 412416 [TBL] [Abstract][Full Text] [Related]
7. [Simultaneous occurrence of myasthenia gravis, epilepsy and struma in childhood]. Mortier W; Schenk K; Kleu G Nervenarzt; 1971 Sep; 42(9):498-501. PubMed ID: 4999164 [No Abstract] [Full Text] [Related]
8. Phenotypic malformations in association with maternal trimethadione therapy. Rosen RC; Lightner ES J Pediatr; 1978 Feb; 92(2):240-4. PubMed ID: 413897 [No Abstract] [Full Text] [Related]
9. Nephrotic syndrome after use of trimethadione and paramethadione in petit mal. Heymann W JAMA; 1967 Nov; 202(9):893-4. PubMed ID: 4964568 [No Abstract] [Full Text] [Related]
10. Possible teratogenicity of trimethadione and paramethadione. German J; Ehlers KH; Kowal A; De George FV; Engle MA; Passarge E Lancet; 1970 Aug; 2(7666):261-2. PubMed ID: 4193708 [No Abstract] [Full Text] [Related]
11. Trimethadione (Tridione)-induced nephrotic syndrome. A report of a case with unique ultrastructural renal pathology. Bar-Khayim Y; Teplitz C; Garella S; Chazan JA Am J Med; 1973 Feb; 54(2):272-80. PubMed ID: 4631174 [No Abstract] [Full Text] [Related]
16. Fetal anticonvulsant exposure: effects on behavioral and physical development. Vorhees CV Ann N Y Acad Sci; 1986; 477():49-62. PubMed ID: 3468838 [No Abstract] [Full Text] [Related]
17. Observations on the discrepancy between the clinical and the laboratory effects of anti-petit mal drugs. Fromm GH; Killian JM; Sanchez F Trans Am Neurol Assoc; 1967; 92():238-40. PubMed ID: 4999959 [No Abstract] [Full Text] [Related]
18. Antibody positive myasthenia gravis following treatment with carbamazepine--a chance association? Kurian MA; King MD Neuropediatrics; 2003 Jun; 34(5):276-7. PubMed ID: 14598236 [No Abstract] [Full Text] [Related]
19. Fetal trimethadione toxicity: an historical footnote. Hecht F Am J Dis Child; 1979 May; 133(5):557-8. PubMed ID: 433884 [No Abstract] [Full Text] [Related]